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Editor’s Note
Dear Colleagues,
This edition of TAPIJ carries many informative articles and some unusual case
reports.
Periodontitis is one of the most common and many times neglected complication
in diabetic patients and the article on this subject draws the attention of the medical
fraternity to this important complication. The importance of central blood pressure and
its role in cardiovascular risk reduction has been highlighted.
There is also an interesting case report on Psoas abscess. Three unique case reports
pertaining to neurology are discussed in detail.
A study to find out the prevalence of the more common serogroup types of
leptospirosis in Central Chennai has been included.
Apart from that we have our regular reports on Toxicology, Dermatology and ECG
section. This edition comes as a combination of various specialities to enlighten you and
will add food for thought.
I request all members of API-TNSC to register for the 7th TAPICON, our annual
conference to be held at Kodaikanal between 25th and 27th March 2011.
With regards,
Dr.Vijay Viswanathan

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A Study on Serogroup Profile of Leptospirosis in Central Chennai
Joseph Navaseelan A*; Raju D**; Shama Prakash K**
ABSTRACT
Aim: To study the serogroup profile of
leptospirosis in Central Chennai.
Materials and Methods: This study was
conducted in governmentt Kilpauk Medical
College and Hospital (KMCH), Chennai between
February 2009 and January 2010 which included
531 patients, clinically suspected of leptospirosis,
of which 240 were males and 291 were females.
Serum samples were collected and macroscopic
slide agglutination test (MSAT) was done as the
screening test for all patients. Microscopic
agglutination test (MAT) was done for
confirmation and detection of serogroups in
patients with positive MSAT.
Results: 268(50.47%) patients showed positive
MSAT, of which 121 were males and 147 were
females. In this study MAT showed the following
sero-prevalence pattern in decreasing order.;
L.grippotyphosa (27.24%), L.icterohaemorrhagiae
(23.88%), L.pomona (19.78%), L.australis (13.8%),
L.bataviae (12.31%), L.canicola (2.61%),
L.autumnalis (0.37%). The seroprevalence in
males and females were 50.42% and 50.52%
respectively.
Conclusions: L.grippotyphosa was the
commonest sero-group followed by
L.icterohaemorrhagiae and L.pomona in Chennai
between February 2009 and January 2010.
Key Words: Leptospirosis, Sero-groups,
Macroscopic slide agglutination test (MSAT),
Microscopic agglutination test (MAT).
INTRODUCTION
Leptospirosis is a well known worldwide
zoonotic disease with a greater incidence in
tropics. In India, Leptospirosis is a grossly
underreported disease probably due to lack of
awareness of the disease among physicians1. The
oetiological agent is Leptospira interrogans which
has 23 serogroups and > 250 serovars, while L.
biflexa is a free living organism and is not
pathogenic to humans .Leptospirae are best
visualised by dark field illumination and phase
contrast microscopy2. A definitive diagnosis is
made by isolation of organism from urine or
blood but it takes time to develop in culture and
growth is unreliable. In the leptospiraemic phase
(< 7 days) diagnosis can be made by culture and
PCR, while serological tests can be used for the
diagnosis during the immune phase ( ≥  7 days).3
Studies4-6 done over a period of time
showed that different types of sero-groups
predominated over different periods of time.
Studies done in 1995-1997 showed L.autumnalis
as the predominant serogroup, while a study
during 2004-2006 reported L.icterohaemorrhagiae
as the predominant serogroup. The goal of the
present study is to study the trend of sero-groups
during the study period in Chennai. Studies have
also reported that leptospirosis is common in
males than females explained by higher
exposures to leptospirosis risk factors like fishing,
butchering and livestock farming among males7.
Hence our study wanted to compare the
seroprevalence of leptospirosis between males
and females.
METHODS
This study was conducted in Kilpauk
Medical College and Hospital, situated in central
Chennai during the period between February
2009 and January 2010. A total of 531 patients
with symptoms of leptospirosis (fever, headache,
myalgia, conjunctival suffusion, jaundice) were
enrolled in the study as suspected cases of
leptospirosis, of which 240 were males and 291
were females. Serum samples were collected from
the patients and sent to an exclusive leptospirosis
Original Articles
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laboratory for serological tests. MSAT was used
as a screening test 8 and was done in all the
patients to detect current infection. MSAT was
done using a dense suspension of killed
leptospirae mixed with a drop of serum on a
slide, rotated on a rotator (120rpm) for 4 minutes
and read in naked eye for agglutination. Those
with agglutination were considered positive and
MAT was done to detect the sero-group.
MAT was performed following a standard
procedure using nine locally prevalent strains as
antigens. The strains belonged to sero-groups
L.australis, L.autumnalis, L.bataviae, L.canicola,
L.grippotyphosa, L.hebdomadis,
L.icterohaemorrhagiae , L.pomona and L.sejroe. A
titre of 1:80 or more was taken as diagnostic
criteria 9.
RESULTS
MSAT showed positive results for 268
patients, out of the total 531 suspected patients
(50.47%). The 268 patients underwent MAT to
detect the specific serogroup. In this study MAT
showed the following seroprevalence pattern in
decreasing order.; L.grippotyphosa 73/268
(27.24%), L.icterohaemorrhagiae 64/268 (23.88%),
L.pomona 53/268 (19.78%), L.australis 37/268
(13.8%), L.bataviae 33/268 (12.31%), L.canicola
7/268 (2.61%) and L.autamnalis 1/268 (0.37%)
(Table 1, Fig.1).
TABLE 1 Distribution of MSAT and MAT
Among
MSAT MALE FEMALE TOTAL
Tested 240 291 531
Positive 121
(50.42%)
147
(50.52%)
268
(50.47%)
MAT
L.grippotyphosa 33 40 73(27.24%)
L.icterohaemorrh
agiae
35 29 64(23.88%)
L.pomona 27 26 53(19.78%)
L.australis 15 22 37(13.8%)
L.bataviae 10 23 33(12.31%)
L.canicola 1 6 7(2.61%)
L.autumnalis 0 1 1(0.37%)
Of the total 268 MSAT positive patients,
121 were males and 147 were females with a
seropositivity of 50.42% and 50.52% respectively
(Fig.2).
This study further noted that the cases
were reported throughout the year with
seropositivity more during monsoon months
(October, November, December, January showing
48, 40, 46, 22 cases respectively) in Chennai
(Fig.3).
DISCUSSION
Studies from different parts of India
showed a sero-prevalence ranging from 17.8% to
40.5% 6,9 . A study conducted in Madras Medical
Fig. 1 Distribution of Cases between Serogroups
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College, Chennai during 2004-06 showed an
increasing trend in the seroprevalence from
14.7% in 2004 to 32.3% in 2006 6. A study done
by Sunil Sethi et al., in 2003 showed
seropositivity of 5% but our study showed a
seropositivity of 50.47% 1. This can be attributed
to the increasing awareness about leptospirosis
among physicians and laboratories but also
contributed by the polluted environment, an
important risk factor for leptospirosis.
A study conducted in Andaman and
Nicobar in 2004 showed seroprevalence of 52.7%
among high risk population and 14.7% among
other population, with L.grippotyphosa being the
commonest serogroup followed by L.australis13. A
study conducted in Calicut showed seroprevalence
of 38.1% among high risk groups and 24 % in
others. L.pomona , L.shermani ,L.canicola were
the common serogroups12 .In a study at
Maharashtra the serovars isolated were L.
Icterohaemorrhagie , L. canicola and L. australis
14. A study conducted in Chennai during 1995-97
showed L.autumnalis as the commonest
sero-group followed by L.icterohaemorrhagiae 4. A
study done in Kolancheri, Kerala during the
same period also showed same sero-groups5.
Shivakumar et al in their study in Chennai
during 2004-06 reported L.icterohaemorrhagiae
Fig. 3. Monthwise distribution of cases from Feb 2009 to Jan 2010
Fig. 2. Distribution of Cases between Sex (Males and Females)
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(48%) as the commonest sero-group followed by
L.australis (37%) and L.grippotyphosa (26%) 6.
Our study showed L.grippotyphosa (27.24%) as
the predominant serogroup followed by
L.icterohaemorrhagiae (23.88%) and L.pomona
(19.78%).
This study noticed that there is no
difference between males and females with
regard to leptospiral seropositivity (males 50.42%
Vs females 50.52%). A study done by Andreas
Jansen et al 10., also found no differences in the
sero-prevalence between males and females,
however it reported a more severe disease
occurring in males while females had a milder
course. In a study by Angnani R et al 11,
sero-prevalence was more common in males
(43.43%) than in females (21.31%) and the low
sero-prevalence noted in females may be due to
milder disease and hence are frequently
underreported.
To conclude, L.grippotyphosa (27.24%)
followed by L.icterohaemorrhagiae (23.88%) and
L.pomona (19.78%) were the predominant
sero-groups in Chennai during the study period.
There was no sex difference in the seropositivity
of leptospirosis. Cases of leptospirosis were
reported throughout the year with peak incidence
during monsoon season. Hence Chennai is
endemic for leptospirosis.
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Periodontitis : The Sixth Complication of Diabetes
T.Sundararaj,* S.Dhinahar**
Abstract
Tissue damage of Diabetes is well known
in causing various micro and macro vascular
complications. The oral complications are
important but often not mentioned even in
textbooks on Diabetes.
Hence a retrospective study was
undertaken to highlight the prevalence of this
complication from a medical college and a dental
college. The study revealed a considerable
number of Periodontitis in Diabetic patients.
Similarly Diabetes was diagnosed in significant
number of Periodontitis patients. This number
was compared with the figures in the literature.
The figures quoted were much higher. Even the
five to seven percent noted in our study is
important while considering the huge number of
diabetics and Periodontitis reported.
Knowing the possible triggering of the
development and progression of
Diabetes in addition to promoting
Coronory and cerebral complications,
Periodontitis should be vigorously treated.
Such patients are to be screened for
Diabetes and prediabetes and are at high
risk.
 	
Periodontitis, AGE, Plaque, gingivitis
Back ground
Tissue damage is well described in
Diabetes Mellitus through proinflammatory
cytokines. Micro vascular complications are the
Hallmark of Diabetes manifesting as
Retinopathy, Neuropathy and Nephropathy.
Macro vascular complications produced in
association with dyslipidemia and Atherosclerosis
manifest as Coronory artery disease, cerebro
vascular disease and Peripheral vascular disease.
The important complication often forgotten
even by textbooks on Diabetes is the oral
complication of diabetes described by some as
sixth complication of diabetes to stress its
importance. (Ref 4) There are many oral
complications of diabetes like Periodontitis,
caries, ulcers and candidiasis.
Among the many complications mentioned
Periodontitis is important as it plays a dual role.
It can trigger the onset of diabetes as well as
its progression in addition to promoting Coronary
and cerebral complications (ref 1) Vice versa
Diabetes will produce severe Gingivitis leading on
to Periodontitis. (ref 1)

	  	
Plaque leads to gingivitis and then to
Periodontitis . Next plaque hardens pulling gums
away from the tooth thus forming pockets of
infection. Subsequently bone is affected loosening
the tooth and ending in loss of tooth.

To show the prevalence of periodontitis in
the diabetic patients as well as the prevalence
of Diabetes in the periodontitis patients and
thereby draw the attention of the medical and
dental fraternity to this (sixth or seventh)
complication of diabetes.
Periodontitis is due to
1. The bacteria thriving in presence of high
sugar.
2. With lazy white cells, AGE (Advanced
Glycosalation End products) with abnormal
*Professor Emeritus,
Tamilnadu Dr.M.G.R.Medical University,
Retired Head of Department of Medicine,
Tirunelveli Medical College, Tirunelveli
**Professor of Orthodontics,
Saveetha Dental College, Chennai.
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collagen binding to monocytes producing pro
inflammatory cytokines causing tissue
destruction.
3. Thickening of blood vessel walls with slow
flow of blood and incomplete removal of
waste products.
4. Reduced healing in Diabetes.
5. Increased susceptibility in Diabetes.
Methods
A study of periodontitis and diabetes at
Tirunelveli medical college and Saveetha dental
college were done for three months January,
February & march 2010.
The statistics of the three month is taken.
Tirunelveli Medical College Dental
Department
Outpatients – 3527 (January 2010); 3482
(February); 3195 (march) = Total 10204
Gum diseases – 1210 (January); 1080 (February)
;1312 (march) = Total 3602
Percentage of gum diseases  = 3602/10204
 = 32.9%  = 33%
Diabetics among them = 180 = 180/3602 = 5%
Saveetha dental college, Chennai
Monthly average outpatients -4082 (January) ;
4310 (February) ; 4474 (March)
           Total = 12866
Gum disease patients – 2392 (January) ; 2613
(February) ; 2142 (march) Total = 7147
Percentage of gum diseases  = 7147/12866
                     = 55%
Diabetics among them  = 352 = 352/7147  = 7%
Refer table 1.1, table1.2, table2.1 and table 2.2
Table 1.1 Outpatient statistics of
Saveetha Dental College, Chennai
PERIOD MALE FEMALE TOTAL
Jan 2010 2329 1753 4082
Feb 2010 2287 2013 4310
Mar 2010 2495 1979 4474
Table 1.2 Number of Periodontitis among
them
PERIOD MALE FEMALE TOTAL
Jan2010 855 679 1534
Feb2010 834 792 1626
Mar2010 796 594 1350
Diabetics confirmed for the three months
– 352.
Table 2.1 Outpatient statistics of dental
department of Tirunelveli Medical College:
PERIOD MALE FEMALE TOTAL
Jan2010 1660 1822 3482
Feb2010 1732 1463 3195
Mar2010 1762 1765 3527
Table 2.2 Gum disease among them
PERIOD MALE FEMALE TOTAL
Jan2010 576 504 1080
Feb2010 702 610 1312
Mar2010 705 505 1210
Confirmed Diabetics among them for the
three months – 180.
An attempt was made to compare this
with the statistics of the diabetic clinic of
Tirunelveli medical college. All cases of Diabetes
were referred to dental and eye department as
a routine. 
Results of the study
Our study gave a figure of 5% of diabetics
in Tirunelveli medical college suffering from
Periodontitis and 7% of Periodontitis patients of
Saveetha dental college, Chennai suffering from
diabetes.
Ideally we should have a 10 year study of
all diabetic patients for Periodontitis and all
Periodontitis patients for diabetes. No such
statistics is available in both colleges.
But a study is available in the following
references
In a recent paper by Dr. Herald Loe,
department of periodontology, University of
Connecticut and Robert J. Genco, State
TAPI Journal Vol 3, Issue 1, January - April 2011
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university of New York described the study in
JADA of 263 patients 9.8 % with type I diabetes
developed periodontal disease in contrast to a
mere 1.7 % in non diabetics. (Ref 4)
In another study on Pima Indians 40 %
of type 2 diabetic had periodontal disease with
alveolar loss. Toothless ness was 15 times more
in type 2 diabetics. Life threatening deep neck
infection and fatal palatal ulcers has been
described arising from Periodontitis.
Thus a strong relation between dental
periodontitis and diabetes has been shown by our
study along with the study quoted in the
literature and also as per the other references.
Conclusion
We have to be on the look out for Diabetes
in all dental departments and dental colleges by
doing a routine blood sugar study. Same way all
diabetic patients should be referred to dental
department to rule out Periodontitis and a
registry should be maintained in the medical and
dental colleges . A portion of the morbidity in
oral complication in Diabetes and its contributory
effect towards other diabetic complications could
be prevented.
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Awareness about HbA1c test in type 2 diabetic patients during
registration in a tertiary care centre in India
Srikanth Medimpudi, Satyavani Kumpatla, Vijay Viswanathan
ABSTRACT
Background: Glycosylated haemoglobin (HbA1c)
testing has become routine practice and
maintenance of HbA1c within the normal range
leads to improved metabolic control. AIM: To
assess the awareness of HbA1c test among type
2 diabetic patients at the time of registration in
a tertiary care centre in India.
Research Design And Methods: We conducted
a cross-sectional survey of 240 (M: F 146:94)
newly registered adults with type 2 diabetes in
a tertiary care centre. Baseline demographic data
of all patients was obtained. A
researcher-administered survey was done to test
patient’s knowledge on HbA1c test, their goal and
their last A1c result. Factors which could
influence the patient’s knowledge of HbA1c were
also recorded.
Results: Only 11% of total patients knew about
HbA1c test. About 69% of those who know about
HbA1c test knew their target goal also. Overall
only 6.7% patients knew about HbA1c test, their
goal and last A1c result. Eighty nine percent
didn’t know about HbA1c test. Low income groups
are more ignorant compared to high income
group. Patients who had not visited the hospital
regularly had poor awareness than who had more
(> 4) visits per year (71.5% vs. 28.5%). Awareness
levels were poor among patients attending a
general physician than patients attending a
diabetes care specialist (57.9% vs. 37.9%).
Conclusion: HbA1c awareness among Indian
patients with diabetes during registration in
tertiary care centre is very poor. Patients with
less number of consultations per year, lower
educational levels, low income and urban hailing
had poor knowledge about the HbA1c test.
INTRODUCTION
Diabetes is a common chronic condition
that can lead to significant morbidity and
mortality [1,2]. Evidences show that achieving
good glycemic control can delay or prevent
complications of both type 1 and type 2 diabetes
[3-5]. The primary goal in the treatment is to
reduce and maintain blood glucose levels in the
near normal range and it provides an opportunity
for patients to live without complications [6].
Glycosylated hemoglobin (A1c) test which provides
an index of a patient’s average blood glucose level
for the past 2-3 months [7], is the most widely
accepted and reliable measure of long-term
glycemic control.
Many factors like age, adherence to
prescribed hypoglycemic medications [8], diet and
life style modification play a significant role in
attaining good control, but awareness about
HbA1c test itself [9] with goal oriented approach
in attaining target A1c is also crucial. Patients
were more likely to follow life style changes when
the importance of maintaining goal A1c for good
glycemic control was stressed. Follow-up visits
with health care providers [10] and self
monitoring of blood glucose also play an
important role in the maintenance of glycaemic
control. Patients’ understanding of HbA1c, its goal
and implications of uncontrolled A1c on long-term
health risk is essential.
Dr.Vijay Viswanathan MD., Ph.D, FRCP(London), FRCP
(Glasgow)
Prof.M.Viswanathan Diabetes Research Centre &
M.V Hospital for Diabetes
(WHO Collaborating Centre for Research, Education
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Patients’ knowledge about diabetes and
HbA1c comes mainly from health care providers.
Clinicians have the opportunity to use this test
to improve diabetes management and they should
discuss about the results with the patients [11].
The use and interpretation of HbA1c results
among physicians [12] have been studied, but
there is paucity in studies of patients’ knowledge,
and understanding of HbA1c testing. The aim of
this study was to assess the awareness about
HbA1c test in type 2 diabetic patients during
registration in a tertiary care centre and to
identify the factors influencing the patient’s
knowledge of HbA1c.
RESEARCH DESIGN AND METHODS
The study subjects were selected from a
tertiary care centre for diabetes in India during
the period of August to October 2007. We studied
240 (M: F 146:94) randomly selected type 2
diabetic patients newly registered in the out
patient department. . Patients of all
socio-economic strata attend the centre for
routine management of diabetes. The study
patients were treated elsewhere for diabetes and
for the first time they had registered in our
centre. All the participants gave informed
consent.
Each patient’s baseline demographic data
on age, sex, location (urban / rural), annual
household income ( ≤  Rs. 100000 or > Rs.
100000), education (illiterate, School/high school,
college) and duration of diabetes were recorded.
Patients were asked to fill up a short
questionnaire designed to obtain information
about anti diabetic medications they were
currently taking (diet, oral medication only,
insulin only, Insulin + OHA), average number of
visits per year that patients had to their health
care provider (including visits to emergency
rooms or hospital admission), whether treated by
a physician / diabetes care specialist / self treated
and asked whether they perform self monitoring
of blood glucose at home or not. The
questionnaire was evaluated in 10 patients in a
pilot study prior to administering it to the study
patients and minimal changes were made prior
to standarization.
A researcher-administered survey was
then employed to assess patients’ awareness
about HbA1c test, their target goal and last
A1c value. Each study patients responded to three
open ended questions including “What does
HbA1c test mean?” (Respondents were classified
as having accurate awareness about the test if
they answered it as overall glycemic control test
or 2-3 months blood sugar average test.
Respondents were coded as unaware of the test
if they answered wrongly or if responded, “I don’t
know.”).
Respondents who were aware of the test
were then asked, “What is your HbA1c goal?” (We
classified respondents as ‘Aware and goal known’
if they mentioned their target goal as less than
7%. Respondents were coded as not knowing goal
if they answered wrongly or if responded, "I don’t
know.”). Respondents who were aware of their
goal were then asked, “What is your last
HbA1c result?” (We classified respondents as
knowing their HbA1c value if their actual test
result was within 0.5 percentage points of the
lower or upper boundary of the mentioned value).
For example, if respondents reported that their
HbA1c was 7, they were grouped as knowing
their HbA1c if their recorded HbA1c was within
6.5-7.5. Respondents were coded as not knowing
their value if their estimate differed by > 0.5%
or if responded, “I don’t know”). Patients who are
unaware of the HbA1c test were educated
regarding the test and their target goal.
Patient’s medical records were reviewed to
confirm the above information as well as to
document respondents’ most recent HbA1c results
taken before the survey. If respondents had no
documented HbA1c results, we recorded this
value as ‘no result’. Mean, standard deviation
and proportions are reported as relevant. SPSS
version 10 © was used for statistical analysis.
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RESULTS
A total of 240 (M: F 146:94) subjects with
type 2 diabetes were enrolled and none of them
refused to participate in the study. The mean age
was 50.2  ±  11.3 years and most patients were
diagnosed with diabetes 5.41  ±  5.2 years prior
to the study. Table 1 shows the demographic and
clinical characteristics of the study subjects. The
majority of patients were hailing from urban
areas (86.3%). Regarding the education levels,
56.3% had a high school education or less, 35.8%
are graduates and 8% are illiterates. About
96.7% had an annual household income of
Rs.100,000 or less. At the time of survey, , 85%
were using oral hypoglycemic agents alone, 14.6%
were using insulin in combination with or with
out oral agents and 0.4% of patients were being
managed exclusively with diet.
Table 1: Demographic and clinical
characteristics of the study subjects
N, M:F 240 (146:94)
Age (years) (Mean, SD) 50.2 ± 11.3
Duration of diabetes (years)
(Mean, SD)
5.4 ± 5.2
Location n (%) 
Rural (n = 33) 33 (13.8)
Urban (n = 207) 207 (86.3)
Education
Illiterate 19 (7.9)
School / High school 135 (56.3)
College 86 (35.8)
Annual income (INR)
 ≤  100,000 232 (96.7)
 >  100,000 8 (3.3)
Treatment
OHA 204 (85)
Insulin OHA 35 (14.6)
Diet 1 (0.4)
Figure 1: Details of awareness about HbA1c test
among the study subjects
Figure 1 shows the details of awareness
about HbA1c test among the study subjects. 89%
(214/240) of the subjects does not know about
HbA1c test, while 11% (26/240) knew about
HbA1c test. 69% (18/26) of those who know about
HbA1c knew their HbA1c goal also and 89%
(16/18) of them remember their last A1C result.
Overall, only 7.5% (18/240) of total patients knew
about HbA1c test and their target goal and 6.7%
(16/240) knew about HbA1c test, their goal and
last A1c result.
Table 2 shows the description of subjects
who are unaware of HbA1c test. A larger
percentage of subjects are hailing from urban
areas (85%) Male preponderance was seen in
unawareness about the HbA1c test. Majority of
the subjects had lower levels of education in this
group of subjects (67.3% vs. 32.7%).
Table 2: Description of subjects who are
unaware of HbA1c test
Gender n (%) 
Men 131 (61.2)
Women 83 (38.8)
Duration of diabetes (years)
 < 10 164 (76.6)
 ≤  10 50 (23.4)
Location
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Rural 32 (14.9)
Urban 182 (85.5)
Education 
Illiterate 19 (8.9)
School / High school 125 (58.4)
Collage 70 (32.7)
Annual income (INR)
 ≥  100,000 207 (96.7)
 >  100,000 7 (3.3)
Frequency of hospital visits per year
 <  4 153 (71.5)
 ≥  4 61 (28.5)
SMBG
Subjects who perform SMBG 40 (18.7)
Subjects who do not perform SMBG 174 (81.3)
Treatment
Self 9 (4.2)
Physician 124 (57.9)
Diabetologist 81 (37.9)
Low income group of subjects are more
ignorant about the test compared to high income
group (96.7% vs. 3.3%). Patients who had not
visited hospital regularly ( < 4 hospital visits per
year) had poor awareness than who had more
( ≥ 4) hospital visits per year (71.5% vs. 28.5%).
Awareness levels are less among patients
attending a general physician than patients
attending a diabetes care specialist (57.9% vs.
37.9%). Higher percentages are unaware about
the test in the group of subjects who do not
perform self monitoring of blood glucose (81.3%
vs. 18.7%).
DISCUSSION:
The present study was done with a
questionnaire and assessed patients knowledge
about HbA1c test during registration in a tertiary
care centre for diabetes in India. Nearly 89% of
the patients do not have knowledge about
HbA1c test. Only 6.7% of the patients knew about
HbA1c test, their goal and last A1c result. In
India, numerous national and international
organizations are working for the past decade in
raising public awareness of the role of HbA1c in
the developmentof diabetes-related complications.
Individual medical health facilities dedicated to
diabetes care also educate their patients about
HbA1c, and motivate their patients in a goal
oriented fashion, but the HbA1c awareness among
Indian patients with diabetes during registration
in a tertiary diabetes care centre is still very poor
as per our study finding. Very few respondents
in our study knew their target HbA1c goal.
A cross sectional study in US population
examined the relationship between patient’s
knowledge of recent HbA1c value and self
management of diabetes. A minority of diabetic
patients knew their most recent HbA1c value and
those who knew their HbA1c values reported
significantly better understanding about diabetes
care [13]. Many of the earlier studies reported
similar findings [14’15]. Contrary to the above
findings, another study conducted in Norway by
Skie etal [16] reported that majority of the
studied type-1 diabetic patients were aware of
their last A1c result and most patients knew their
target HbA1c.
In our study majority of subjects who are
unaware about the test are hailing from urban
areas. They had lower levels of education and
most of them belong to low income group.
Patients who have not visited hospital regularly
and patients attending a general physician had
poor awareness about the HbA1c test. A high
percentage of subjects are unaware in the group
of subjects who do not perform self monitoring
of blood glucose.
A study in the United States showed that
66% of patients did not know their last A1c result
and only 25% accurately reported the value.
Knowledge of A1c result was associated with
higher educational levels []. Low levels of
education were one of the reasons for
unawareness about the test in our study.
Knowledge about the test was poor despite
majority of subjects are from urban areas.
In an earlier study we found that majority
of patients who attend a tertiary care centre for
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diabetes care knew about HbA1c test and half of
them were aware about their target goal.
Awareness about the test had a positive impact
on maintenance of better glycaemic control
(unpublished). Knowing about A1c test,
particularly target goal motivates patients to
effectively manage their diabetes, as well as
positively reinforces those patients who are
already effectively managing their diabetes.
Scientific advances and advantages must be
translated into practical steps, so that patients
can use them to improve their health. There
should be an increased focus on encouraging
patients to be aware of and discuss specific
information pertaining to their diseasestatus and
markers, such as HbA1c, blood pressure, and lipid
values with their clinicians.
CONCLUSION:
In conclusion, our study showed that type
2 diabetic patient’s knowledge about HbA1c test
was very poor during registration in a tertiary
care centre for diabetes. Low levels of education,
less number of hospital visits, non performance
of self monitoring of blood glucose were
associated with unawareness about the HbA1c
test. Clinicians should provide information about
this test and discuss their glycaemic goals to
improve diabetes management.
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TYPHOID – A review in the 21st century
P.Senthur Nambi*, D.Sureshkumar*, V.Ramasubramanian**
Typhoid fever is a systemic disease
characterized by fever and abdominal pain and
is caused by dissemination of Salmonella Typhi.
Salmonella is a gram-negative,
non–spore-forming, facultatively anaerobic
bacillus. Salmonellae are named for the
pathologist Salmon, who first isolated S.
choleraesuis from porcine intestine.1 The disease
was initially called typhoid fever because of its
clinical similarity to typhus (typhus like =
typhoid). However, in the early 1800s, typhoid
fever was clearly defined pathologically as a
unique illness on the basis of its association with
enlarged Peyer’s patches and mesenteric lymph
nodes. In 1869, given the anatomic site of
infection, the term enteric fever was proposed as
an alternative designation to distinguish typhoid
fever from typhus.Paratyphoid fever is a similar
illness caused by S. Paratyphi A, B, or C.
Typhoid fever is a global health problem.
It has been estimated that approximately 17
million cases of typhoid fever and 600 000
associated deaths occur annually.2 The disease is
endemic in many developing countries,
particularly in the Indian subcontinent,
Southeast Asia, South and Central America, and
Africa, with annual incidence rates estimated to
be greater than 900 per 100,000 population in
India.3 Typhoid fever also has a very high social
and economic impact because of the
hospitalization of patients with acute disease and
the complications and loss of income attributable
to the duration of the clinical illness.4
Transmission
Humans are the only natural host and
reservoir for S.typhi & S.Paratyphi. The highest
incidence occurs where water supplies serving
large populations are contaminated with faeces
of infected persons. Waterborne transmission
involves the ingestion of fewer microorganisms
and, as a result, has a longer incubation period
and lower attack rate compared with foodborne
transmission. Ice cream is recognized as a
significant risk factor for the transmission of
typhoid fever. Shellfish taken from contaminated
water, and raw fruit and vegetables fertilized
with sewage, have been sources of past
outbreaks. Although direct person-to-person
transmission is uncommon, person-to-person
transmission of S. Typhi, including anal-oral
transmission, has been reported.5 Health care
workers can acquire the disease from infected
patients as a result of poor hand hygiene or
handling laboratory specimens.6
Pathogenesis
All Salmonella infections begin with
ingestion of organisms in contaminated food or
water. The infectious dose is 103–106
colony-forming units. Conditions that decrease
stomach acidity (age < 1 year, H2 blockers or
proton pump inhibitor ingestion) increase
susceptibility to Salmonella infection.Once
Salmonella reach the small intestine, they
penetrate the mucous layer of the gut and reside
within Peyer’s patches. After crossing the
epithelial layer of the small intestine, they are
phagocytosed by macrophages and disseminate
throughout the body in via the lymphatics and
reach the reticuloendothelial system (liver,
spleen, lymph nodes, and bone marrow.
Signs and symptoms
Typhoid fever is characterised by a slowly
progressive fever as high as 40°C (104°F),
abdominal discomfort, and non bloody diarrhoea.
The incubation period for S. typhi averages
10–14 days but ranges from 3 to 21 days, with
the duration likely reflecting the inoculum size
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and the host’s health and immune status. The
most prominent symptom is prolonged fever
(38.05 ° − 40.5°C; 101.8 ° − 104.9 °C, which can
continue for up to 4 weeks if untreated.
The term Enteric fever is a misnomer, in
that the hallmark features of this disease—fever
and abdominal pain are variable. Thus, a high
index of suspicion is necessary when a person
presents with prolonged fever in endemic areas.
S. Paratyphi A is thought to cause milder disease
than S. Typhi, with predominantly
gastrointestinal symptoms. However, a
prospective study of 669 consecutive cases of
enteric fever in Kathmandu, Nepal, found that
the infections were clinically indistinguishable.7
Frequency of common symptoms 7
headache 80%
anorexia 55%
chills 35 to 45%
cough 30%
abdominal pain 30 to 40%
diarrhoea 22 to 28%
nausea, vomiting 18 to 24%
myalgia 20%
constipation 13 to 16%
arthralgia 2 to 4%
Physical findings included coated tongue
(51–56%), splenomegaly (25–30%), and abdominal
tenderness (5-10%). In endemic areas, most
patients presenting to hospitals with enteric fever
are between 5 and 25 years of age. When
children younger than 1 year of age acquire
typhoid, the disease is often more severe and is
associated with a higher rate of complications.8
In the second week of the infection, fever
plateaus around 40 $C (104 $F) and bradycardia
may develop. Relative bradycardia is neither a
sensitive nor a specific sign of typhoid fever,
occurring in fewer than 50% of patients.9, 10 Rose
spots appear on the lower chest and abdomen in
around a third of patients. Diarrhea can occur
in this stage; however, constipation is also
frequent. The spleen and liver are enlarged and
tender.
In the third week of typhoid fever, a
number of complications can occur:
• Intestinal hemorrhage due to bleeding in
congested Peyers’ patches
• Intestinal perforation in the distal ileum. It
may occur without alarming symptoms until
septicemia or diffuse peritonitis sets in.
• Encephalopathy
• Metastatic abscesses, cholecystitis,
endocarditis and osteomyelitis
Neuropsychiatric manifestations, including
apathy, psychosis, and confusion, occur in 5% to
10% of patients and may be related to cytokine
release from S. Typhi infected macrophages.12
Seizures and coma are reported in less than 1%
of persons, and seizures may represent febrile
seizures of childhood. The cerebrospinal fluid
usually is normal, and abnormal CSF studies or
recurrent seizures should suggest another
diagnosis.11
 Salmonella have a propensity for infection
of vascular sites, and high-grade or persistent
bacteremia suggests an endovascular infection or
endocarditis.12 The risk of endovascular infection
complicating Salmonella bacteremia is estimated
to be 10% to 25% in persons over 50 years of
age, usually involves the aorta, and most
commonly results from seeding atherosclerotic
plaques or aneurysms. Mortality rates range from
14% to 60% and are lower with prompt diagnosis
and combined medical and surgical therapy.
Venous septic thrombophlebitis also has been
reported.13
Chronic Carrier State
The chronic carrier state is defined as the
persistence of Salmonella in stool or urine for
periods greater than 1 year. Up to 10% of
untreated patients with typhoid excrete S. Typhi
in the faeces for up to 3 months, and 1% to 4%
develop chronic carriage. The frequency of chronic
carriage is higher in women, in persons with
biliary abnormalities or concurrent bladder
infection with Schistosoma haematobium, and in
infants. Chronic carriage of S. Typhi and S.
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Paratyphi A has been associated with an
increased incidence of carcinoma of the
gallbladder and of other gastrointestinal
malignancies.14 Serology for the Vi antigen can
be useful in distinguishing chronic carriage from
acute infection with S. Typhi, because chronic
carriers will often have a high antibody titer to
this antigen.15 A person may become an
asymptomatic carrier of typhoid fever, suffering
no symptoms, but capable of infecting others.
Diagnosis
The definitive diagnosis of typhoid fever
depends on the isolation of S. typhi from blood,
bone marrow or a specific anatomical lesion.
Majority of the patients have normal WBC counts
and in 15–25% of cases, leukopenia and
neutropenia are detectable. Eosinopenia could
give a diagnostic clue.16 Leukocytosis is more
common among children and in cases complicated
by intestinal perforation or secondary infection.
Other nonspecific laboratory findings include
moderately elevated liver transaminases and
muscle enzyme levels.
Blood culture is the mainstay of the
diagnosis of this disease. More than 80% of
patients with typhoid fever have the causative
organism in their blood. A failure to isolate the
organism may be caused by several factors:
1. The timing of collection, patients with a
history of fever for 7 to 10 days are more
likely to have a positive blood culture.
2 The volume of the specimen cultured17
3. Prior receipt of antibiotics
Bone marrow aspirate culture is the gold
standard for the diagnosis of typhoid fever and
is particularly valuable for patients who have
been previously treated, who have a long history
of illness and for whom there has been a negative
blood culture.18 Duodenal aspirate culture has
also proved highly satisfactory as a diagnostic
test but has not found widespread acceptance
because of poor tolerance of duodenal aspiration,
particularly in children.19
Widal test
This test measures agglutinating antibody
levels against O and H antigens. Usually, O
antibodies appear on days 6-8 and H antibodies
on days 10-12 after the onset of the disease. The
test is usually performed on an acute serum. A
convalescent serum should preferably also be
collected so that paired titrations can be
performed. In practice, however, this is often
difficult.
The test has only moderate sensitivity and
specificity. In areas of endemicity there is often
a low background level of antibodies in the
normal population. Determining an appropriate
cut-off for a positive result can be difficult since
it varies between areas and between times in
given areas.20
False negatives -It can be negative in up
to 30% of culture-proven cases of typhoid fever.
This may be because of prior antibiotic therapy
that has blunted the antibody response.
False positives - S. typhi shares O and H
antigens with other Salmonella serotypes and
has cross-reacting epitopes with other
Enterobacteriacae, and this can lead to
false-positive results. Such results may also occur
in other clinical conditions, e.g. malaria, typhus,
bacteraemia caused by other organisms, and
cirrhosis. Prior typhoid vaccination can also give
a false positive result.
Hence, widal test should not be used as
a diagnostic test in endemic areas.
New diagnostic tests: current status and
usefulness
There is a need for a quick and reliable
diagnostic test for typhoid. Recent advances
include the IDL Tubex test which reportedly can
detect IgM O9 antibodies from patients within a
few minutes. Another rapid serological test,
Typhidot, takes three hours to perform. It was
developed for the detection of specific IgM and
IgG antibodies against a 50 kD antigen of S.
typhi. A newer version of the test, Typhidot-M,
was developed to detect specific IgM antibodies
only. All these tests require validation before
being applied in large scale.
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DNA probes and PCR for detection of S.
Typhi in blood have been developed and appear
to be more rapid and sensitive than standard
culture but are not yet commercially available
and are impractical in many areas where typhoid
is endemic.21
EVOLUTION OF ANTIBIOTIC
RESISTANCE IN TYPHOID
Antimicrobial resistance in developing
countries may be promoted by the widespread
use of “over-the-counter” antibiotics, immigrant
workers, and international travel.
Chloramphenicol, ampicillin or amoxicillin and
trimethoprim-sulfamethoxazole formerly were
widely used for treatment of typhoid. In the
1970s, chloramphenicol-resistant strains emerged
in Mexico and the Indian subcontinent.22
Beginning in 1989, multidrug-resistant strains of
S. Typhi, with plasmid-encoded resistance to
chloramphenicol, ampicillin, and trimethoprim,
emerged in the Indian subcontinent, Southeast
Asia, the Middle East, and Africa, and resulted
in numerous outbreaks with substantial
morbidity and mortality.23
More recently, chromosomal and plasmid
encoded resistance to ciprofloxacin has appeared
among S. Typhi isolates from the Indian
subcontinent, Vietnam, and Tajikistan, associated
with the widespread use of ciprofloxacin to
control outbreaks of multidrug-resistant S. Typhi
infection.24,25 High-level resistance to
third-generation cephalosporins has been
reported but remains rare.26 Although
multidrug-resistant strains remain common in
many areas of Asia, in certain areas sensitive
strains have reemerged.
TREATMENT
Fluoroquinolones appear to be the most
effective drugs for the treatment of typhoid;
especially in areas where quinolone resistance is
uncommon.27 Fluoroquinolones are highly active
against S. Typhi in vitro and achieve high
concentrations in macrophages and in bile. They
are rapidly effective, with cure rates of up to
98%, fever resolution in an average of 4 days and
lower rates of relapse. They are proven to be safe
for the treatment of multidrug-resistant typhoid
in children and pregnant women.28
When S. Typhi strains are relatively
quinolone resistant (MIC of ciprofloxacin of 0.125
to 1 ìg/mL), they should be treated with higher
doses of ciprofloxacin or ofloxacin (10 mg/kg twice
daily) for 10 to 14 days. Patients with S. Typhi
strains with MIC values of ciprofloxacin of 2
ìg/mL or greater should be treated with a
third-generation cephalosporin or azithromycin.29
Ceftriaxone (1 to 2 g daily in adults or 60 mg/kg
daily in children) administered either
intravenously or intramuscularly for 10 to 14
days or oral cefixime (15 to 20 mg/kg twice daily
for 14 days) results in cure rates of 95%.30
First- and second-generation
cephalosporins are clinically ineffective and
should not be used to treat typhoid fever or
nontyphoidal salmonellosis, despite adequate in
vitro killing activity. Aminoglycosides also are
clinically ineffective, perhaps because they lack
activity against intracellular Salmonella.When
untreated, typhoid fever persists for three weeks
to a month. Death occurs in between 10% and
30% of untreated cases.
TREATMENT OF UNCOMPLICATED TYPHOID
Optimal therapy Alternative therapy
Susceptibility Antibiotic Daily dose
mg/kg
Duration Antibiotic Daily
dose
mg/kg
Duration
Fully sensitive Ciprofloxacin 15 14 Chloramphenicol 100 14 - 21
Amoxicillin 100 14
TMP-SMX 8 - 40 14
Multidrug resistance Ciprofloxacin 15 14 Ceftriaxone 60 14
Quinolone resistance Ceftriaxone 60 14 Ciprofloxacin 20 14
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TREATMENT OF SEVERE TYPHOID
Optimal therapy Alternative therapy
Susceptibility Antibiotic Daily dose
mg/kg
Duration Antibiotic Daily dose
mg/kg
Duration
Fully sensitive Ciprofloxacin 15 14 Chloramphenicol 100 14 - 21
Amoxicillin 100 14
TMP-SMX 8 - 40 14
Multidrug resistance Ciprofloxacin 15 14 Ceftriaxone 60 14
Quinolone resistance Ceftriaxone 60 14 Ciprofloxacin 20 14
The use of glucocorticosteroids has been
advocated in the treatment of severe typhoid
fever based upon a study in Jakarta that showed
a significant reduction in mortality among
patients with severe typhoid fever (i.e., associated
delirium, obtundation, stupor, coma, or shock).10
Although the study has never been repeated,
dexamethasone 3 mg/kg intravenously followed
by eight doses of 1 mg/kg every 6 hours should
be considered in the treatment of severe typhoid
with altered mental status or shock. Steroid
treatment beyond 48 hours may increase the
relapse rate.31
Up to 5 - 10% of patients develop mild
relapse, usually within 2 to 3 weeks of fever
resolution and associated with the same strain
type and susceptibility profile. Reinfection may be
distinguished from relapse using molecular
typing. 32 A relapse does not imply resistance and
treatment is similar to the initial episode.
Prevention
Sanitation and hygiene are the critical
measures that can be taken to prevent typhoid.
Typhoid does not affect animals and therefore
transmission is only from human to human.
Typhoid can only spread in environments where
human feces or urine are able to come into
contact with food or drinking water. Careful food
preparation and washing of hands are crucial to
preventing typhoid. Public education campaigns
encouraging people to wash their hands after
defecating and before handling food are an
important component in controlling spread of the
disease. According to statistics from the United
States Centre for Disease Control and Prevention
(CDC), the chlorination of drinking water has led
to dramatic decreases in the transmission of
typhoid fever in the U.S.
There are two vaccines currently
recommended by the World Health Organisation
for the prevention of typhoid: 33
1. The live, oral Ty21a vaccine
2. The injectable Typhoid polysaccharide vaccine
(sold as Typhim Vi by Sanofi Pasteur and
Typherix by GlaxoSmithKline).
The efficacy is between 50% to 80%. The
typhoid vaccines currently available do not offer
protection against S. Paratyphi infection .The
vaccine is recommended for both people living in
endemic areas and travelers to areas where
typhoid is endemic.
CONCLUSION
1. Typhoid is one of the common causes of
community acquired acute undifferentiated
febrile illness in our country.
2. Blood culture helps in establishing the
diagnosis, Widal test is not reliable.
3. Quinolone resistance is widespread.
4. Ceftriaxone or Azithromycin should be the
empiric therapy of choice.
5. Typhoid is a vaccine preventable disease.
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Central blood pressure lowering and cardiovascular prevention
Vijay Viswanathan*
Historically, brachial artery pressure has
been the gold-standard surrogate measure of
antihypertensive drug efficacy. This reflects the
ease with which pressure can be assessed
non-invasively in the upper arm and also the
wealth of epidemiological data relating brachial
blood pressure to future cardiovascular risk.
However, blood pressure varies throughout the
arterial tree due to differences in vessel stiffness
and the influence of wave reflections. Moreover,
it is the pressure in the central, not peripheral
arteries to which the major organs are exposed.
A range of techniques are now available with
which to assess central blood pressure and in the
recent years there has been a growing awareness
of the importance of central blood pressure in the
pathogenesis of cardiovascular disease. Indeed,
evidence that central pressure is a better
predictor of cardiovascular events1 than
peripheral pressure measured conventionally at
the brachial artery is now emerging.
A simple non-invasive method to measure
the central aortic pressure is applanation
tonometry. The system is called sphygmocor
which has been approved by USFDA.2
Antihypertensive agents differ in their
ability to lower central aortic blood pressure,
despite similar reduction in brachial BP.3 Until
recently, the consensus view was that blood
pressure reduction matters more than the choice
of antihypertensive drugs. Fortunately,
consideration of changes in central blood pressure
helps resolve this apparent paradox.
The Conduit Artery Function Evaluation
(CAFÉ) study was the first large-scale
prospective randomized trial investigating
whether different BP-lowering treatment
strategies have different effects on central aortic
pressures and thus cardiovascular outcomes
despite similar effects on brachial BP.4
The CAFÉ investigators assessed central
blood pressure in a cohort of 2199 individuals
who participated in the main ASCOT5 study
comparing an atenolol/bendroflumethiazide-based
regimen with an amlodipine/perindopril-based
one. Despite identical reductions in peripheral
blood pressure between the two groups of
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subjects enrolled into the substudy, aortic systolic
pressure was some 4.3mmHg lower, and aortic
pulse pressure 3.0mmHg lower, in those
randomized to the amlodipine-perindopril
regimen arm.
Although modest, this differential effect
could explain most of the observed difference in
outcome in the main ASCOT study.
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A Case of PSOAS ABSCESS : Case Report
Ashwin Subramaniam* Nupur Dravid** Porselvi* Chitra Ayyappan# 
G. Ananthasubramaniam##
ABSTRACT
Psoas muscle abscess is a rare condition
with vague clinical presentation, which presents
a diagnostic challenge requiring a high index of
suspicion. We report a case of psoas abscess in
a patient with no co-morbids who presented as
undiagnosed fever for three months.
Key words 
psoas abscess, pain, fever
INTRODUCTION
Psoas abscess may be classified as primary
or secondary, depending on the presence or
absence of underlying disease. Primary psoas
abscess is a rare clinical entity with subtle and
non specific symptoms, most commonly seen in
immunosuppressed patients or those predisposed
to infections. It has no definite etiology. The
psoas muscle has a rich vascular supply that is
believed to predispose it to hematogenous spread
from sites of occult infection. Psoas abscess can
also be secondary to gastrointestinal or renal
pathology through direct infection of adjacent
structures. The most common causes are
appendicitis, diverticulitis, Crohn’s disease and
carcinoma. The organisms responsible for
infection are gram-negative germs (Escherichia
coli, Klebsiella spp., Pseudomonas aeruginosa,
Proteus mirabilis Enterobacter spp.) and
gram-positive cocci (Staphylococcus aureus,
Staphylococcus epidermidis, Streptococcus
agalactiae, α-hemolytic streptococci, especially
Streptococcus mitis). It can also be of tuberculous
etiology and associated with cold abscesses of
lower thoracic and upper lumbar vertebral
bodies, as the psoas is attached to these
vertebrae. Percutaneous drainage and antibiotics
provide an effective and safe alternative to more
invasive surgical drainage in most patients.
Surgical drainage is associated with shorter
hospital stay.
CASE REPORT
A 50 year old lady with no co-morbids
presented to our outpatient department with
history of fever for the past three months. Fever
was high grade, intermittent, not associated with
chills and rigors. She had been extensively
investigated in various centres for fever but was
not diagnosed. Baseline blood investigations were
within normal range and clinical examination did
not reveal any localising signs for fever. Mantoux
was positive 40 by 30 mm. A routine ultrasound
abdomen showed a left retroperitoneal mass
encasing the left upper ureter causing left
hydronephrosis anterior to left psoas muscle. CT
scan revealed a multiseptate hypodense cystic
space occupying lesion involving left psoas muscle
encasing left ureter causing left hydronephrosis.
The patient was referred to a surgeon and the
abscess was surgically drained. Histopathological
examination showed granulomatous
inflammation. He was started on clindamycin and
anti tubercular drugs. Subsequently the pus grew
tubercle bacilli.
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DISCUSSION
Anatomy [1]
The psoas muscle is a retroperitoneal
muscle that originates from the lateral borders
of the 12th thoracic to fifth lumbar vertebrae and
inserts in the lesser trochanter of the femur. In
70% of people, it is a single structure (psoas
major), but 30% also have a smaller psoas minor
muscle, which lies anterior to the psoas major
along the same course. It is innervated by
branches of L2, L3, and L4 nerves before the
formation of the femoral nerve. The psoas muscle
lies in close proximity to many other organs,
including the sigmoid colon, jejunum, appendix,
ureters, aorta, renal pelvis, pancreas, iliac lymph
nodes, and spine. Thus, infections in these o
rgans can contiguously spread to the psoas
muscle. The psoas muscle has a rich vascular
supply that is believed to predispose it to
hematogenous spread from sites of occult
infection.
Epidemiology [1]
Mynter first described psoas abscess in
1881 refereeing as psoitis. Psoas abscess is a
relatively uncommon condition in western
countries. Psoas abscess may be classified as
primary or secondary, depending on the presence
or absence of underlying infection. Primary psoas
abscess occurs probably as a result of
haematogenous spread of an infectious process
from an occult source in the body. Incidence of
psoas abscess was 12 cases per year worldwide
in 1992. This was a significant increase from the
calculated occurrence of 3.9 cases per year before
1985. The increase was attributed to improved
diagnosis with the widespread use of computed
tomography. Primary psoas abscess is most
prevalent in young patients and occurs rarely in
the elderly population. Certain groups of
immuno-compromised patients, such as diabetics,
the elderly, patients on steroids, patients with
malignancies, and alcoholics, usually present
with infrequent sites of infection. A primary
psoas abscess is predominant in developing
countries; however, in the western world primary
psoas abscess has become more prevalent,
especially in immunocompromised patients. This
group includes intravenous drug users,
HIV-infected persons and patients with chronic
illness or malignancies. In a large review the
most common cause of secondary psoas abscess
was Crohn’s disease (60%). Other causes are
appendicitis (16%), ulcerative colitis,
diverticulitis, colon cancer (together 11%) and
vertebral osteomyelitis (10%) [Table 1].
Table 1 PREDISPOSING CONDITIONS
Disease Site Conditions
Gastrointestinal Diverticulitis, appendicitis,
Crohn’s disease, colorectal
carcinoma, appendiceal tumor
Genitourinary Urinary tract infection,
extracorporeal shock wave
lithotripsy, cancer
Musculoskeletal Vertebral osteomyelitis, lumbar
spondylodiskitis, infectious
sacroiliitis, septic arthritis
Other Endocarditis, femoral artery
catheterization, infected
abdominal aortic aneurysm,
hepatocellular carcinoma, trauma,
intrauterine contraceptive device,
acupuncture, spinal surgery
sepsis, suppurative adenitis,
long-term hemodialysis or
peritoneal dialysis
Bacteriology [1,3,6]
Staphylococcus Aureus is the causative
organism in over 88% of patients with Primary
Psoas Abscess, Streptococcus species 4.9% and
Escherichia coli 2.8%. Other rare pathogens
reported are Mycobacterium tuberculosis,
Streptococcus species, Escherichia coli, Salmonella
enteritidis, Pneumococcal, Pseudomonas
aeruginosa, Proteus Mirabilis, Yersinia
enterocolitica, Bacteroides, Pasteurella multocida,
Klebsiella, Serratia marcescens Mycobacterium
kansasii, and Mycobacterium xenopi. Methillicin
resistant Staphylococcus aureus is also known
pathogen also known pathogen. In secondary
psoas abscess cultures are often mixed, with E.
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coli and Bacteroides spp predominating. Other
organisms include enteric pathogens,
Staphylococcus spp and Streptococcus spp.
Diagnosis [1-5]
The classical symptoms of patients with
primary psoas abscess are fever, flank or
abdominal pain, and limp. Other symptoms may
include malaise, weight loss, or presentation with
a mass. Physical findings, such as external
rotation of the ipsilateral hip, flank tenderness,
and fullness of the flank may be seen. Laboratory
tests may reveal raised white cell count,
anaemia, and elevated erythrocyte sedimentation
rate, as with our case, and bacteriological
confirmation of microorganism is utmost
importance.
Radiographic imaging studies help in
diagnosis and may also help in finding an
underlying cause. Plain abdominal x-ray may
reveal an abnormal psoas shadow or a soft tissue
mass. Ultrasound of the abdomen may
demonstrate a hypoechoic mass suggestive of
psoas abscess, but cannot identify the cause of
the abscess. CT scan of the abdomen with
contrast is the most efficient and accurate
imaging study in diagnosing a PA. CT scanning
is now used as the first line of investigation. CT
scan of the abdomen not only helps in diagnosis,
but also in identification of the etiology, for
therapeutic purposes, and postoperative
follow-up. CT scan is also valuable in
differentiating between tumor , hematoma and
abscess of the ilio – psoas compartment.
The most reliable CT features of each
condition were as follows: [5]
• Irregular margins 67% sensitive, 52% specific
and 57% accurate for neoplasm
• Low attenuation 100% sensitive, 43% specific
and 70% accurate for the abscess
• Diffuse involvement of the entire muscle 88%
sensitive, 78% specific and 80% accurate for
hematoma
Treatment [1,2,4]
An adequate knowledge of the causative
organisms should guide the initial choice of
antibiotics. But at the same time the importance
of bacteriological confirmation of micro organism
involved should not be ignored. It has been
suggested that in primary psoas abscess,
antistaphylococcal antibiotic therapy should be
started before final bacteriologic diagnosis .
However, the identification of non-staphylococcus
organisms in some patients with primary psoas
abscess and the identification of staphylococcus
in patients with secondary psoas abscess, makes
it prudent in all cases of psoas abscess to start
treatment with broad spectrum antibiotics like
cephalosporins, quinolones, imipenem and
clindamycin pending final bacteriologic diagnosis.
Antibiotics are sometimes continued up to four
to six weeks after complete drainage of the
abscess. Drainage can be surgical or radiological.
Percutaneous drainage may be difficult in some
patients because of the location of the abscess,
but whenever possible it should be employed.
Even in patients with complex, multiloculated
abscesses, percutaneous drainage should be
attempted and open surgical drainage should be
reserved if percutaneous drainage fails. Patients
with secondary psoas abscess require correction
of their underlying disease in addition to the
drainage procedure. Extra-peritoneal drainage is
a safe, effective method of draining these
abscesses. Compared to percutaneous drainage,
an advantage with open drainage is that
debridement of adjacent tissues can be done,
which may help in shortening recovery time.
Prognosis [1]
With appropriate treatment the prognosis
is generally good. Primary psoas abscess has a
better p rognosis, the mortality rate being only
2.4%. Secondary psoas abscess has a mortality
rate of 18.9%. The major cause of death is
delayed or inadequate therapy. Mortality in
un-drained cases approaches 100%, with sepsis
being the usual cause of death
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Conclusion
High index of clinical suspicion is required
for the diagnosis of psoas abscess. We also
emphasises the importance of imaging techniques
as CT scan and bacteriological confirmation of
microorganism involved, although Staphylococcus
aureus remains the commonest pathogen.
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Listen to the Patient he is Giving us the Diagnosis
S.R.Chandra*, Ranjith Sanu Watson, Vivek Purvshothaman, C.S.Vidhya Annapoorni
ABSTRACT
Three patients with neurological symptoms
who received treatment based on laboratory data
with little regard to clinical history is discussed.
Tumors and tumefactive demyelination are
a challenge to Radiologist, Pathologist and
Surgeon as they share several common features.
Correlation with clinical onset and evaluation of
laboratory data in the light of clinical history will
only clinch the diagnosis and help to avoid
potentially harmful treatments. A third case of
incidentaloma being implicated as causal in a
patient who in fact had a non epileptic attack
disorder of psychological origin and responded to
Psychotherapy and not surgery.
LISTEN TO THE PATIENT HE IS
GIVING US THE DIAGNOSIS
Introduction
Unlike any other system nervous system
is spread all over the body so that it controls
the function of every other system. So disorders
of nervous system can present with
neuro-psychiatric symptoms, hemispheric
symptoms restricted or global, symptoms of
various sub-cortical, brainstem, spinal cord or
lower motor neurons. More over as nervous
system is the master system controlling other
systems, it can present with symptoms referable
to other systems also. Investigations done
without proper and thorough clinical history can
result in a situation where the investigator
targets soft innocuous lesion that are incidental
causing great therapeutic errors. With more and
more technological advances, this is more and
more relevant because these are very sensitive
techniques and pick up shadows, which need
careful assessment. Here we report the history
of three such cases.
Case I
Nine-year-old female child studying in 4th
standard reported to neurology department,
Trivandrum in the year 2006 with the following
history. She was born to non-consanguineous
parents and was doing well till August 15, 2005.
She developed sudden onset dragging of left leg,
which steadily worsened over the next one week.
She was seen by pediatrician on August 22 and
investigated with CT scan head. It showed an
irregular hypo dense leision in the right parieto
occipital area with minimal contrast
Enhancement and no mass effect. The
possibility suggested by radiologist was glioma.
She underwent MRI scan which was reported as
ill defined intra axial lesion hypodense in T1 and
heterogeneously hyperintense in T2 and flair,
images involving right parieto occipital white
matter, extending to splenium of corpus callosum
and crossing the mid line. Lesion measured 6x
6 x 5 cms on contrast with peripheral rim
enhancement seen with central non-enhancing
cystic necrotic area suggestive of anaplastic
astrocytoma (fig (1) fig (2)). Based on this she
underwent surgery on 3rd September 2005. The
operation notes were as follows. Duratense brain
Figure 1 cystic lesion
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surface normal. AT one-centimeter depth
yellowish grey hypovascular firm to soft tumor
seen infiltrating the surrounding brain diffusely
there was no clear demarcation or encapsulation.
Adequate decompression done. Postoperative
period uneventful. Histopathology report showed
brain tissue with moderately cellular neoplasm
composed of astrocytes with eccentrically placed
nucleus and abundant eosinophilic cytoplasm and
areas of perivascular lymphocytic cuffing is seen
(fig 3,4,5). These pictures are consistent with
gemistocytic astrocytoma. The slides were
reassessed and reported as oligoastrocytoma and
patient underwent thirty-three cycles of
irradiation starting on 15th November 2005.
Patient had worsening of left hemiparesis at that
time and evaluated with CT Scan which showed
oedema and was treated with antioedema
measures by neurosurgeon. (Figure (6)) CT Scan
Figure 2 enhancing ring
Figure 3 eosinophilic cytoplasm eccentric nucleus s/o
gemistocytes
Figure 4 perivascular cuffing
Figure 5 increased cellularity
Figure 6 edema 
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repeated one week later showed resolution of
oedema (figure(7)). November 2006 patient
developed dysarthria, dysphasia and difficulty in
walking. Her optic-fundus was normal. She had
bilateral facial weakness with sparing of
emotions. Tongue was spastic palate was moving
sluggishly and had bilateral pyramidal signs.
This was her first visit to neuromedicine
department. Possibilities considered were
recurrence of glioma Vs radiation induced
demyelination.
MRI brain was repeated during this visit
in 2006 and it showed gliotic right peritrigonal
and posterior high parietal region leision with
focal atrophy, the post contrast images showed
incomplete open ring enhancement of left middle
frontal gyrus with diffuse white matter hyper
intensities involving periventricular and sub
cortical white matter seen over both fronto
parietal regions (Figure 8). The histopathology
slides were reassessed. The slides were stained
with luxal fast blue for myelin. There was loss
of myelin with preserved Axons in the white
matter. There was perivascular astrocytic
proliferation and now the opinion was
demyelination (figure 9,10) the child’s diagnosis
was revised as recurrent tumefactive
demyelination and treated with methyl
prednisolone for five days and followed up with
oral steroids. She recovered very well and
returned to school by four weeks she was left
with residual left hemi paresis and she continues
to be on follow up. This case indicates that
demyelination can radiologically and
Figure 7 resolution of edema
Figure 8 incomplete open ring
Figure 9  demyelination
Figure 10 inflammatory cell proliferation
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histopathologically resemble neoplasm and unless
carefully correlated with clinical course and
assessed only in the light of clinical picture the
patient may be wrongly subjected to serious
management strategies like radiation and
surgery which are contraindicated in the above
condition.
CASE II
A forty years old politician reported to out
patient department of government medical college
hospital neuro medicine department with slurred
speech as his first symptom of illness and
possibility of a lacunar stroke was considered. He
was investigated for all risk factors. CT head
done at that time was normal hence patient was
started on anti platelet agents, as outpatient.
However patient experienced deterioration and
shifted to a higher centre on the third day of
illness MRI done showed T2 hyper intensities
confined to white matter with moderate
enhancement with contrast. And there was mild
involvement of carpus callosum hence infiltrating
lesions like lymphoma was considered at that
centre and steriotactic biopsy was attempted
thrice and failed. Hence he shifted to another
center where successful biopsy was done. Patient
reported back with diagnosis of astrocytoma to
the second center and was subjected to
radiotherapy on the eighth day of his illness. He
steadily deteriorated and succumbed in the third
week of his illness. We could not acquire any of
his images or histopathology material for the
current presentation even though they were all
personally verified by a team of neurologist later
as the patient got discharged against medical
advice from our institute the same is not
available for publication now.
The learning from this case is that corpus
callosum and white matter leisions which are
mildly enhancing with contrast are seen with
demyelinating diseases which are medically
treatable. However radiology and histology can be
misleading if not correlated clinically and can
result fatally if managed with wrong treatment
options purely based on laboratory data without
clinical picture.
CASE III
Thirty years old female presented with
history of recurrent attacks of loss of
consciousness of three months duration she gave
definite history of stress preceding the same.
Semiology of the attacks was as follows sudden
falls preceded by call for help, her eyes remain
closed with spitting of saliva. She had no tongue
injury or incontinence she was having out off
phase movements involving all four limbs. The
attacks lost about thirty minutes and stop when
water is sprinkled, she was not showing any
postictal confusion or vomiting she was
investigated elsewhere with a CT scan and she
was found to have a well defined lesion in the
right parietal region (figure 11) with no mass
effect or oedema. She was referred to the surgeon
and underwent excision (figure 12) however she
continued to have these attacks and hence she
was referred to neuro-medicine department and
her interictal EEG was normal. Her attacks.
were witnessed and found to be non epileptic she
recovered completely with the help of
psychiatrist. The patient had psychogenic
seizures, the best investigative tool for that is
witnessing the attack by a trained neurologist or
a careful description of semiology by an
intelligent eye witness. In this case the patient
Figure 11 heterotopia right parietal
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was operated based on a benign congenital lesion
seen in the imagings which had no contributory
role for the patients symptoms.
Discussion
Patients one and two both had a brief
rapidly progressive illness. None of them had
features of raised intracranial tension. Image
characteristics when reassessed the lesions
involved periventricular white matter and carpus
collosum, mass effect was minimal. Contrast
enhancement was very minimal, patient one also
showed the open ring sign.
Histologically presence of evidence of
tissue necrosis and gemistocytes are nonspecific
unless correlated with clinical and radiological
picture. Special stains were not considered in the
first instance, as the information provided to the
pathologist was with reference to radiological
diagnosis reported and not correlated
clinicoradiologically.
Tumefactive demyelination is a challenge
for the Neurosurgeon, Pathologist and
Radiologist.
The lesions presents with varying
combinations of headache, seizures and focal
neurological deficit.Often supratentorial solitary
leisions of more than 20 mm size is seen. No
past history of Multiple Sclerosis, vaccinations or
infections is found. (1)Mostly monophasic and
occasionally relapsing could be intermediate
disorder between Multiple sclerosis and acute
disseminated encephalomyelitis. (2)Radiologically
the features are as follows.
They are seen as solitary leisions
predominantly involving white matter with or
without involvement of grey matter. Prefers
supratentorial compartment and shows very little
oedema.(1)Contrast shows incomplete ring
enhancement open towards cortical grey matter.
The enhancing edge represents the leading edge
of demyelination and this favours the white
matter side(4). Faint central enhancement due to
dilated venous structures occurs which is often
the cause for confusion with neoplasm. Apparent
diffusion coefficient will show increased diffusion
within the leision. Spectroscopy consisting of
elevated choline, suppressed NAA, detectable
levels of lipid and lactate due to necrosis.
Magnetization transfer values are
indistinguishable from tumours. Mean relative
cerebral blood within the leisions is lower
compared to gliomas and lymphomas(3). Hence
magnetization transfer and mild contrast
enhancement should be considered as soft
radiological signs in the contest of a rapidly
progressive neurological illness of hours to days.
Histologically demyelination shows foamy
macrophages intermingled with reactive
astrocytes. Varying degrees of myelin loss is seen
in axons. (5) Gemistocytic astrocyte is a plump
astrocyte which results from injury to nervous
tissue. Hence accepted criteria for gemistocytic
astroctoma needs more than 20% gemistocytes.
More specific features of tumour are dense glial
cell proliferation with astrocytic
differentiation,moderate nuclear pleomorphism,
microvascular proliferation and pseudopalisading
necrosis. Immunohistochemical stain will show
m16-1 in tumor cell nuclei indicating high
proliferation rate.(6) Careful history taking often
reveals a acute onset illness with rapid
progression which when carefully correlated with
open ring enhancement with sparse mass effect
and histology showing inflammatory
demyelination with or without less than 20%
gemistocytes will lead to correct diagnosis. Once
diagnosed good response to steroids is observed
and recurrence is relatively rare.
Figure 12 patient 3
TAPI Journal Vol 3, Issue 1, January - April 2011
32
Patient III is a clear indication to
remember that many patients have asymptomatic
incidentalomas which often do not have a causal
relationship to the patients problem. Hence for
efficient healthcare delivery there is no substitute
for thorugh clinical evaluation.
Conclusion
Thorough clinical history obtained from a
reliable informant is mandatory in all patients
with a neurological symptom. All investigations
should be planned only in the light of the history
and examination and approach to diagnosis and
treatment should be always a team work.
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An Interesting Case of Early Onset of Cerebral Edema During
Diabetic Ketoacidosis Treatment - A Case Report
M. Varalakshmi, T. Palaniappan, R. Sanjay Srinivasan, V. Mohan*
ABSTRACT
A young girl with type 1 diabetes
presented with diabetic ketoacidosis due to
missing of insulin following a respiratory tract
infection. Within the first hour of starting
intravenous fluids and insulin she developed
cerebral edema. This case is being reported
because of the unusual presentation of early
onset of cerebral edema in the management of
DKA and to emphasize the importance of
recognizing this complication early as it helped
to save this patient.
KEY WORDS
Cerebral Edema, Diabetic Ketoacidosis,
Type 1 Diabetes, Asian Indians, South Asians
CASE REPORT
An eleven year old girl, a known case of
type 1 diabetes of one year duration was
admitted in the emergency department in a
tachypenic state. She had missed her insulin
injections for two days following a respiratory
tract infection. She was diagnosed to have
Diabetic Ketoacidosis (DKA) based on
Investigations which revealed very high blood
sugars, elevated serum and urinary ketones with
a high HbA1c. Arterial Blood Gas analysis
revealed uncompensated severe metabolic
acidosis (PH – 7.183, PCO2 − 9.2, PO2 − 122.9 ,
HCO3 − 3.4). There was also evidence of
hyponatremia and hyperkalemia, C-peptide
showed absence of pancreatic beta cell reserve
(Fasting: < 0.3pmol/ml, Stimulated: < 0.3
pmol/ml) and Glutamic Acid Decarboxylase
antibody was positive (> 150 IU/ml).
She was treated with antibiotics as per
institutional protocol. She was started on Intra
venous fluids with normal saline (according to
her body weight) along with IV insulin infusion.
500 ml of NS was transfused in the first hour.
Immediately after this she developed intense
headache and it got worsened with continuing iv
infusion.She also had a bout of vomiting and her
B.P shot up to 150/100 mmHg. A clinical
diagnosis of cerebral edema was made and she
was given 75 ml of iv mannitol over 20 minutes.
With this her headache subsided dramatically
and her B.P came down to 130/82 mm Hg. She
improved after 8 hours of aggressive treatment
and made a total recovery.
DISCUSSION:
We report on a rare case of cerebral edema
that set in immediately after starting therapy for
DKA. DKA in children may be associated with
cerebral edema. Although uncommon (~ 1%),this
complication is associated with a high mortality
rate (about 25%) and neurological
complications[1]. It is known that over-aggressive
rehydration (especially with relatively hypotonic
fluids) can cause cerebral edema but there is
little or no evidence to support this theory[2]. In
the face of extracellular hypertonicity, brain cells
undergo complex metabolic changes. “Idiogenic
osmoles” are produced in the brain to limit brain
cell shrinkage[3]. There is increased intracellular
production of osmotically active substances such
as myoinositol and taurine. It seems logical that
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rapidly administered hypotonic fluid will rush
into brain cells and result in cerebral
edema.However, in experimental animals,
aggressive insulin therapy is more likely to be
associated with cerebral edema than aggressive
fluid therapy[4,5]. While soda bicarbonate would
lower the ECF H + concentration, this should
only become important for Na+ entry into brain
cells when their NHE (Na +/ H + exchanger) is
activated. If this is true, a combination of a bolus
of insulin together with NaHCO3 and
administration of both early in time could make
this “trio” become important risk factors for
cerebral edema. In contrast, if insulin and
NaHCO3 were administered later when the Blood
brain barrier is more intact, they might be less
likely to cause cerebral oedema[6].
Cerebral edema is the most common cause
of mortality and morbidity during the first day
of conventional treatment for diabetic
ketoacidosis in paediatric patients. It is possible
that therapy contributes to its development[7,8].
Risk factors that predispose to cerebral edema
should lead to an expansion of the intracellular
and/or the extracellular fluid compartment(s) of
the brain because water normally accounts for
close to 80% of the brain weight. With respect
to the intracellular fluid compartment, the
driving force to cause cell swelling is a gain of
effective osmoles in brain cells and/or a
significant decline in the effective osmolality of
the expansion of the intracerebral extracellular
fluid compartment [9,10]. Factors leading to an
expansion of the intracerebral extracellular fluid
volume can be predicted from starling forces
acting at the blood-brain barrier [11]. It is implied
that current fluid and electrolyte management
might contribute to the development of cerebral
edema [12,13]. Part of the reason for this is that
clinicians do not have good data to predict how
large the deficits of sodium,potassium and water
are likely to be in this population because they
can be quite variable in individual patients [14,15].
Thus maybe cerebral edema is a
potentially devastating complication that occurs
in the first day of therapy for DKA. It is
commonly seen 5-15 hours after therapy. It is not
known to set in within the first one hour of
starting therapy for DKA and this is the first
such report to our knowledge.
CONCLUSION
Cerebral edema is a relatively uncommon
complication following fluid replacement. This
case report emphasises the point that cerebral
edema can occur as early as within an hour after
starting treatment for DKA. Fluid replacement
must therefore be given very cautiously. A high
index of suspicion can help make a clinical
diagnosis of cerebral edema at an early stage and
can save the patient as in this case.
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Toxicology clinics-bench to bed side
Rodenticide poisoning : An Update
S.SenthilKumaran1, N.Balamurugan2, V.Karthikeyan3
Rodenticides are a category of pest control
chemicals intended to kill rodents. These are
heterogeneous group of compounds that exhibit
markedly different toxicities in humans and
rodents. They are among the most toxic
substances kept at homes. Patients with
rodenticides poisoning present with a spectrum
of manifestations ranging from gastrointestinal
symptoms to severe bleeding manifestations. In
this context let us learn more about rodenticides.
What are the types of rodenticides
available in the market?
Rodenticides are broadly classified into
non anticoagulant and anticoagulant compounds.
Table 1: Non Anticoagulant compounds:
nature and toxicity
Nature of the compound Nature of toxicity
• Arsenic Highly toxicity
• Barium carbonate
• Strychnine
• Thallium sulphate
• OPC
• Yellow phosphorous
• Zinc phosphide
• Aluminium phosphide
• Vacor
• A- Naphthalurea
• Cholecalciferol Moderate toxicity
Table 2: Anticoagulant compound
derivatives and generic name
Derivative Generic name
Coumarin derivatives • First generation: warfarin
• Second generation:
Brodifacoum, Coumuforyl,
Difenacaum
Indandiones • Diphacinone,
chloropacinone
What are the clinical features of
rodenticide poisoning?
The signs & symptoms depends on the
type of compound.
• Anticoagulant rodenticides are toxic to
virtually every organ /system in the body and
the signs and symptoms may vary from
asymptomatic to active bleeding.
The important clinical and laboratory
manifestations of other non anticoagulant
rodenticides are as follows:
• Arsenic – Cardiovascular collapse
• Barium carbonate - Hypokalemia, hypotonia
and paralysis
• Strychnine - Muscular spasms, twitches,
hypersensitivity to stimuli and convulsions
• Thallium sulfate – Polyneuritis, alopecia,
alteration in blood pressure
• Organophosphate compounds – ‘SLUDGE
[Salivation, lacrimation, urination , defecation,
gastrointestinal upset and Emesis,
• Yellow phosphorous - Oral Burns, abdominal
pain, GI bleed& “Smoking” luminescent stool
• Zinc or Aluminium phosphide - Acidosis,
cardiovascular collapse, wide spread cellular
toxicity
• Vacor- Hyperglycemia, ketosis and
neuropathies
Toxicology
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• Cholecalciferol - Hypercalcemia, osteomalacia
and calcifications
• Red Squill - Digoxin-like activity
• Bromethalin – Neurotoxic & Uncouple
oxidative phosphorylation
• Norbormide - vasoconstriction with ischemia
• Super warfarin -asymptomatic to active
bleeding manifestation
What is super warfarin?
The evolution of the warfarin resistance in
rats has resulted in the development of a new
class of rodenticides that are long-acting and
more potent. These second-generation
anticoagulant rodenticides are known as Super
warfarin. They have no role in human
therapeutic anticoagulation.
Which superwarfarin compound is used
commonly?
Brodifacoum is the most common active
ingredient in commercially available rodenticides
usually found in a 0.005% concentration. It is
used in agricultural and urban settings for rodent
control and available in the forms such as solid,
granular and pellet bais.
How does it act?
It acts by blocking the activation of
vitamin K. When vitamin K is not regenerated,
the clotting factors II, VII, IX and X cannot be
activated (extrinsic pathway) and coagulopathy
develops.
How it presents?
The clinical manifestations after ingestion
range from being asymptomatic to active bleeding
such as hematuria, vaginal bleeding,
hematemesis, melaena, soft tissue bruising,
epistaxis, haemoptysis, hemarthrosis,
retroperitoneal and intracranial haemorrhage.
The coagulopathy may last weeks to months and
can be associated with significant overall blood
loss. Toxic hepatitis has been reported after 3 to
4 days even with single exposure.
What are the Laboratory investigations
to be done?
Most patients seek medical attention many
days after ingestion with evidence of
coagulopathy. In the acute phase, the INR and
PT should be reassessed every 6 hours and
repeated if prolongation is observed until the
level plateaus. In suspected long-acting
anticoagulation overdose, twice-daily INR
evaluation for 2 days is essential to identify most
patients at risk of coagulopathy. Assessment of
glycemic status, electrolytes, liver function test
and arterial blood gas analysis are warranted
depending on the clinical picture. The presence
of superwarfarin can be estimated by special
blood assays.
Can we employ gastric lavage?
Gastric decontamination can be employed
with in 6 hours in cases of rodenticide poisoning
but gastric lavage with water is contraindicated
in case of phosphide compound poisoning. Recent
literature suggest that gastric lavage with
coconut oil in such cases prevent the release of
phosphine gas.
Is there any role of activated charcoal in
rodenticide poisoning?
Even though convincing data on the
efficacy of either single or multiple-dose activated
charcoal (AC) are lacking, at least a single dose
may be administered unless contraindicated.
What is the role of blood transfusion in
rodenticide poisoning?
In the case of haemorrhagic shock, active
bleeding, impaired oxygen transport or
emergency surgery, blood transfusion with fresh
whole blood is indicated, as it contains both
cellular components and coagulation factors.
Fresh frozen plasma is used in life-threatening
coagulopathy secondary to super warfarin toxicity
as it immediately reverts by replacing active
vitamin K-dependent coagulation factors.
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What is the antidote for superwarfarin
poisoning?
Vitamin K1 (phytonadione) is the specific
antidote for super warfarin poisoning. It helps in
the hepatic synthesis of coagulation factors II,
VII, IX, and X. Vitamin K2 (menaquinone) or
Vitamin K3 (menadione) are not effective
and reliance on treatment with these or
their analogues can lead to serious
consequences.
Which is the preferred route?
Vitamin K1 is available in several
formulations such as oral, subcutaneous,
intramuscular or intravenous. In superwarfarin
poisoning intravenous injection of Vitamin K1 is
preferred, as it produces immediate response, but
there is a risk of non-allergic, non-IgE mediated
anaphylaxis. Early oral therapy is equally
effective in patients with symptomatic
coagulopathy and who is not on activated
charcoal. Subcutaneous vitamin K1 should be
avoided as its absorption is unpredictable.
Likewise, intramuscular vitamin K1 may be
discouraged as it may cause intramuscular
haemorrhage.
How to give intravenous vitamin K1?
Vitamin K1 Injection (Phytonadione
Injectable Emulsion, USP) is supplied as 1 ml
ampoule at the concentration of 10 mg/ml. The
required dose may be diluted with 100 ml of 0.9%
sodium chloride injection or 5% dextrose injection
and it’s infused over 30 to 60 minutes, not
exceeding 1 mg per minute.
What are the adverse reactions of
parental administration of vitamin K1?
Rarely, intravenous administration of
vitamin K can produce severe, shock-like
reactions. Deaths have been reported after
intravenous and intramuscular administration.
These reactions are generally as a result of too
rapid administration (> 1 mg/minute).
What is the optimum dose of vitamin K1?
A starting dose of 100 mgs of vitamin
K1 may be given per day in four divided doses.
The optimal dosage regimen thereafter remains
unclear but should be titrated to correct the INR.
The daily vitamin K dose required may be up
to 600 mg depending on the severity of
coagulopathy. The doses should aim to return
INR to therapeutic, not normal concentrations.
How long vitamin K1 is needed?
Vitamin K1 should be administered
continuously at high doses and for prolonged
periods of time; for example 100 mg daily for
many days, weeks, and even months. This can
vary from 2 months to a year depending on the
half life of the compound ingested and the
severity.Initially parenteral vitamin K1 is often
indicated, and oral route may be preferred if
long-term administration is required.
Is there any role on prophylactic vitamin
K1?
The administration of prophylactic vitamin
K1 in an asymptomatic patient immediately after
exposure to super warfarin with no laboratory
evidence of coagulopathy is not indicated, as this
may mask the onset of anticoagulant effects in
the few patients who do require prolonged
treatment and follow-up care.
What to do in case of unintentional
single ingestions of super warfarin?
It is often seen in children who ingest a
small dose of a warfarin-based rodenticide, INR
prolongation is unusual. A diet rich in vitamin
K such as spinach, sprouts and broccoli may be
encouraged.
Sum up:
• Remember that rodenticide compounds are
variable and hence, make sure of the
compound before you treat.
• Obtain a baseline PT/INR and arrange for
repeated measurement
• Administer high dose of vitamin K1  for a
prolonged period
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• Observe allergic reactions while administering
vitamin K1
• Lack of data on transfer of superwarfarin
compounds across the placenta or excretion in
breast milk
• Treat any co-ingestions and/or comorbid
illnesses, if any
• Avoid drugs that may enhance bleeding or
decrease metabolism of the anticoagulant
• Treat serious hemorrhage with FFP
• use recombinant factor VIIa (rFVIIa) or
prothrombin complex concentrate (PCC) if
available
• Evaluate the patient for suicidal intention
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Dermatology Photo Feature
Jayakar Thomas*
This 15-year-old obese boy was seen with
velvety dark discoloured plaque over the axillae.
The lesions were asymptomatic and were present
for the past two years (see image).
DIAGNOSIS
Acanthosis nigricans
Definition/ Description
Acanthosis nigricans (AN) is a disorder
that may begin at any age. It causes velvety,
light-brown-to-black, markings usually on the
neck, under the arms or in the groin. Acanthosis
nigricans is most often associated with obesity.
AN is sometimes known as a paraneoplastic
phenomenon, but this is very rare; much more
commonly, AN occurs in relation to endocrine
disease. It can also occur as an idiopathic or
hereditary disorder.
Clinical picture/Investigations 
The clinical features are coffee-colored or
gray-brown velvety and papillomatous thickening
of the skin around the nape of the neck, axillae
(see Image), antecubital fossae, and groin. In the
malignant type, palms, soles, and oral and ocular
mucosae are also often involved; this should be
suspected in older patients with weight loss,
whereas the insulin-resistant patients are most
often either young or the obese elderly. The
endocrine associations have been grouped
together under the term HAIR-AN
(hyperandrogenism, insulin resistance, AN).
Insulin resistance leads to chronic
hyperinsulinemia, which in turn stimulates
increased ovarian production of testosterone and
also has growth-promoting effects on fibroblasts
and keratinocytes to produce the clinical features.
Insulin resistance may occur as primary
and secondary forms; it is common in obesity,
which explains AN in this context. The primary
types have been divided into type A (young
patients with severe AN and hyperandrogenism,
who have decreased numbers or function of
insulin receptors) and type B (older women with
less severe AN, who have blocking autoantibodies
that bind to the insulin receptors).
Other causes of hyperandrogenism, such
as polycystic ovary, ovarian dermoid and other
ovarian lesions, may also cause this syndrome,
as may other causes of insulin resistance, such
Dermatology
*Professor & Head
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Sree Balaji Medical College & Hospital, Chennai
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as lipoatrophic diabetes and pineal lesions. Drugs
such as estrogens, corticosteroids, nicotinic acid,
and recently somatotropin have been documented
as causes of AN.
Biopsy of AN shows hyperkeratosis,
acanthosis, and papillomatosis with increased
pigments in the basal layer - purely non-specific.
Treatment
Treatment is that of the underlying
disorder where possible, weight loss, and topical
agents such as emollients or keratolytics.
Metformin may help to normalize the background
endocrine abnormalities. Treatment to just
improve the appearance includes topical 0.025 to
0.05% tretinoin, 20% urea, alpha hydroxyacids,
and lactic or salicylic acid prescriptions.
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ECG - Section
Diagnose the ECG
Ulhas M. Pandurangi*
Answer for the previous issue: 
The first half of the Trace - WPW syndrome.
Next half of the ECG Trace - Disappearance of
Pre-Excitation with T-wave memory sign.
This ECG is a good demonstration of secondary
ST-T changes occurring during
Pre-Excitation and soon after disappearance of
Pre-Excitation.
 
Question: The ECG of A Patient with Recurrent Syncopal Episodes is shown above.
        What is the Diagnosis? 
*Senior Consultant Cardiologist &
Electrophysiologist and Interventional Cardiologist,
Madras Medical Mission, Chennai,
Tamilnadu
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QUIZ
QUIZ: E.C.G.
Questions
(a) What are the striking features in this ECG?
(b) What is the inference from these findings?
(c) What is the commonest condition that can
   produce these findings?
Answers for the previous issue
(a) Analysis of this monophasic R wave gives us
the clue that   :
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(b) Detection of Right ventricular hypertrophy is
difficult but not impossible
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(c) As the changes are seen in all the precordial
leads  and other evidences are lacking to say
it is RBBB
(d) Left  atrial enlargement is also evident .
(e) The different QRS pattern may provide a
clue to the degree of elevation in right
ventricular pressure, in general qR or rSR’
pattern Incomplete RBBB tells us that Right
ventricular pressure exceeds (qR) is equal to
(R or rR) or it is lower than (rsR’) the left
ventricular pressure respectively, eg severe
pulmonary stenosis or pulmonary
hypertension (qR), Tetrology of Fallot,
Eisenmenger’s complex (R or rR), and atrial
septal defect (rsR’) respectively.
Dr.P.Alagia Nambi, 
Prof. & H.O.D Internal Medicine
Sri Gokulam Hospital, Salem, 636 004, T.N.
Vice Chairman, TNAPI.
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NEWS FROM API CITY CHAPTERS IN TAMIL NADU
The Association of Physicians of India, Tirunelveli Chapter in association with Department of Medicine, 
thTirunelveli Medical College, had organized a CME programme ' MEDICINE UPDATE 2010' on 19  September 
2010 at the Medical college premises.
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rd 3 From Left (Dr.K.Vijayakumar, Executive Committee Member, API TN Chapter,   Dr.S.S.Annamalaisamy, 
Ex-officio Member, API TN Chapter, Dr.S.Arulrhaj, Member, Governing Council, Central API, Dr.Vijay 
Viswanathan, Chairman, API Tamilnadu Chapter,  Dr.D.Selvaraj, Chairman, API Thoothukudi chapter, 
Dr.S.Rajan, Hon.Secretary, API Thoothukudi chapter )
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TAPIJ accepts contributions in the form of
Original Articles, Reviews, Updates, Recent
Advances, Case Reports, Letters to editor, Clinico
pathological conferences, Short reports, etc.
Manuscripts will be reviewed with the
understanding that they are being submitted only
to this journal and have not been published,
simultaneously submitted, or already accepted for
publication elsewhere.
Peer review
Manuscripts should be prepared in accordance
with “Uniform Requirements for Manuscripts
submitted to Biomedical Journal” (N Engl J Med
1991; 324: 424-28 or Br Med J. 1991; 302: 338-41)
developed by International Committee of Medical
Journal Editors.
Submit manuscript and figures in a heavy paper
envelope, accompanied by a covering letter and
permission to reproduce previously published
material or to use illustrations that may identify
subjects. The Document of Consent (attached
herewith) would have to be included with your
articles duly signed by all authors and contain a
statement that the manuscript has been seen and
approved by them. The typed manuscript should
be sent as original copy to the Editor, TAPIJ.
1. EACH TABLE SHOULD BE ON A SEPERATE
SHEET OF PAPER.
2. ARTICLES SHOULD BE TYPED IN A
STANDARD MICROSOFT WORD FORMAT.
3. With each diskette, a printout of manuscript
must be sent in the event of CD damage/virus.
Typed manuscript on white bond paper, with
margins of at least 2.5 cm. Number pages
consecutively, beginning with the title page. The
manuscript should be typed in double space and
should include consecutively title page, abstract
and key words, text, acknowledgements,
references, tables and legends.
In the title page, the full names of all authors
with their latest qualification, the name of the
laboratory or the department/institution and its
address should be mentioned clearly. Also indicate
address for correspondence and reprints.
A running title not exceeding 45 spaces should
be provided.
Abstract: It should be concise and should cover
all the important aspects of the paper. The abstract
format will be those used by Index Medicus/
Medicine headings of Index Medicus, should be
150-250 words for all articles, except case reports
where it should be around 50 words only.
Key words: A maximum of 5 key words typed
well below the summary/abstract, separated by a
line typed across the whole page.
Introduction: This should comprise of;
(1) purpose of the study/article (2) brief references
to pertinent literature only. The introduction should
not be an extensive review of the subject.
Patients and methods: This should include the
following: (1) Selection of observational or experi
mental subjects and the controls, (2) Analytical/
therapeutic/surgical methods used. If these are in
common use, identify them only by references. If
not common, give a brief description, (3) Statistical
methods used.
Results: The results should be presented in the
text, tables, and illustrations. Do not repeat in the
text all the data in the tables and/or illustrations.
Emphasize or summarize only important
observations. Do not include discussion of your
results and do not refer to observations of other
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workers in this part of your text; these usually
should be included in the Discussion.
Discussion: This should emphasize the new
and important aspects of the study and conclusions
that follow from them. Do not repeat in detail data
given in the results section. Include in the
discussion the implications of the findings and their
limitations and relate briefly the observations to
relevant studies.
Tables: Each table should be typed on a
separate sheet and give a number and caption.
Explain in footnotes all nonstandard abbreviations
that are used in each Table. Cite each table in
the text in consecutive order. If you use data from
another published or unpublished source, obtain
permission and acknowledge fully. The same data
should not normally be presented in both tabular
and graphical form.
Photographs should be of good quality and on
glossy paper. Illustrations and graphs should be
drawn on thick white paper with India ink. They
should not be pasted on papers. The numbers
should be marked at the back in pencil and the
top should be marked by arrow. Legends should
be typed on a separate sheet. Each should be brief
but sufficiently descriptive to be complete by itself.
All the References given in the ’reference list’
must be only those cited in the text. Reference
should be arranged in the order of appearance in
the text. Citation in the text should be as
superscribed. Only those articles which have been
read by the authors must be listed. The rest must
be given as quotes. Each original article/review
article requires at least 30 references whereas a
short report or case report may suffice with 5. Also
relevant Indian references on the subject must be
quoted.
The pattern of References should be as follows.
Article from a Journal: List the first 3 authors
with initials. The remaining authors may be given
et al., e.g. Glogar D. H., Konar R. A., Muller J.,
et al; Fluorocarbons reduce myocardial ischaemic
damage after coronary occlusion, Science. 1981;
211: 1439-41. (Note Punctuations)
Articles from a Book: Yokoyana K, Suyama T,
Naito R Development of Fluosol D. A., And its
perspective as a blood substitute. In: Oxygen and
life, proceeding of the second Pristley conference.
Royal Society of Chemistry, London, 1908; 142-52.
(Note punctuations)
The whole of the literary matter in The TAPIJ
is copyright and should not be reproduced without
the written permission of the Editor.
Authors’ responsibility: The author is
responsible for all statements in the work. Views
expressed in the articles in interpreting conclusions
from the data presented shall be the responsibility
of the authors. The accuracy and completeness of
the references is author’s responsibility.
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